UPMC: Monoclonal Antibody Treatment Reduces Risk Of HospitalizationsUPMC announced Friday that they are making significant headway with a developing COVID-19 treatment: monoclonal antibodies.
Daily Covid-19 Minute: Regeneron’s Antibody CocktailDrug maker Regeneron has just released data from their phase 3 clinical trial showing their antibody cocktail, when given to high-risk, non-hospitalized covid patients, reduces the risk of..
MVHS offering Monoclonal antibody therapy treatmentMVHS is offering a treatment to COVID-19 patients that may keep them out of the hospital, but the treatment also comes with some restrictions.
There's a glimmer of hope for those fighting COVID-19 in western Maryland.
![UPMC: Monoclonal Antibody Treatment Reduces Risk Of Hospitalizations [Video]](https://video.newsserve.net/300/v/20210326/2103261716-UPMC-Monoclonal-Antibody-Treatment-Reduces-Risk-Of-Hospitalizations.jpg)
![Daily Covid-19 Minute: Regeneron’s Antibody Cocktail [Video]](https://video.newsserve.net/300/v/20210326/2103261306-Daily-Covid-19-Minute-Regeneron-Antibody-Cocktail.jpg)
![MVHS offering Monoclonal antibody therapy treatment [Video]](https://video.newsserve.net/300/v/20210317/7709799-MVHS-offering-Monoclonal-antibody-therapy-treatment.jpg)
